2012, Number 4
<< Back Next >>
Correo Científico Médico 2012; 16 (4)
Genetic Variants in Breast Cancer
Ortigoza GRI, Soca PEM, Machín BD
Language: Spanish
References: 7
Page:
PDF size: 93.34 Kb.
Text Extraction
No abstract.
REFERENCES
1 Álvarez Estrabao OA, Cruz Mariño T, Concepción Osorio M, Cardet Escalona M, Díaz Armas MT. Asesoramiento genético sobre el cáncer de mama. Correo Cient Méd Holguín. 2012 [citado 18 oct 2012];16(2). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/506/70
2 Miguel Soca PE, Almaguer Herrera A, Ponce de León D, Sales Márquez H, Pérez Rodríguez H. Correo Cient Méd Holguín. 2007 [citado 1 nov 2012];11(3). Disponible en: http://www.cocmed.sld.cu/no113/n113rev1.htm
3 McElwee JL, Mohanan S, Griffith OL, Breuer HC, Anguish LJ, Cherrington BD, et al. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer. 2012 [citado 3 nov 2012]; 12:500. Disponible en: http://www.biomedcentral.com/1471-2407/12/500
4 Ma J, DeFrances MC, Zou C, Johnson C, Ferrell R, Zarnegar R. Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. J Clin Invest. 2009;119(3):478-91.
5 Bos PD, Zhang XHF, Nadal C, Shu W, Gomis RR, Nguyen DX, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009; 459: 1005-9.
6 Domchek SM, Greenberg RA. Breast cancer gene variants: separating the harmful from the harmless. J Clin Invest. 2009; 119(10):2895-7.
7 Pern F, Bogdanova N, Schürmann P, Lin M, Ay A, Länger F. Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7in a hospital-based series of German patients with triple-negative breast cancer. PLoS ONE. 2012 [citado 4 nov 2012]; 7(10): e47993. doi:10.1371/journal.pone.0047993.Disponible en: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047993;jsessionid=C06C65788A67B1B13C1E7EC32CA407E6
Full text